Understanding Schizophrenia Spectrum Disorders & Addiction
Schizophrenia is a severe psychotic disorder characterized by disturbances in thought processes, perception, and emotional experience. Individuals with schizophrenia frequently experience positive symptoms including delusions (fixed false beliefs) and hallucinations (perceptions without sensory input), as well as negative symptoms including reduced emotional expression, diminished motivation, and social withdrawal. The condition typically emerges in late adolescence or early adulthood and profoundly disrupts education, employment, relationships, and social functioning.
The co-occurrence of schizophrenia and substance use disorders represents one of the most challenging and common dual diagnoses in psychiatric treatment, with research indicating that 40% to 50% of individuals with schizophrenia will develop a substance use disorder at some point in their lives. The relationship is bidirectional and complex: individuals with schizophrenia use substances at rates far exceeding the general population, while substance use can also precipitate or exacerbate psychotic symptoms. Cannabis is particularly problematic, as multiple studies demonstrate that early cannabis use increases the risk of developing schizophrenia in genetically vulnerable individuals, and continued cannabis use dramatically worsens existing psychotic symptoms. Stimulants like methamphetamine and cocaine can produce acute psychotic episodes that are indistinguishable from schizophrenia, complicating diagnosis and treatment.
Self-medication is a significant factor driving substance use in schizophrenia: individuals use alcohol, cannabis, and stimulants to manage the unbearable psychological experience of psychotic symptoms, to counteract the emotional flatness and apathy of negative symptoms, or to achieve a sense of social belonging. At Trust SoCal, our dual diagnosis program provides integrated treatment that carefully manages antipsychotic medications, addresses psychotic symptoms, and treats the substance use disorder within a coordinated, evidence-based framework.